Merck Life Science and India's DPIIT have partnered to boost the nation's biotech startup scene. This joint effort under the Startup India initiative will provide emerging companies with access to cutting-edge technologies and resources, fostering innovation and new product development.
Merck Life Science signed a Memorandum of Understanding (MoU) with the Department for Promotion of Industry and Internal Trade (DPIIT) towards a `Viksit Bharat'.
This collaboration under DPIIT's Startup India initiative aims to build a stronger India by empowering its emerging biotech startups and providing access to work-of-art global technologies that deliver, foster, and promote the manufacturing ecosystem of the nation towards Viksit Bharat. The initiative will encourage and motivate emerging biotech startups, innovators and entrepreneurs by nurturing ideas and amplifying new product development by overcoming the valley of death.
About the Author
Rupali Mukherjee

A business journalist with around two decades of experience tracking key consumer-focussed sectors like consumer durables, retail, consumer goods, aviation, automobiles and advertising, as well as economic ministries of the Union government. Now, writes primarily on pharmaceuticals and healthcare, and on issues of consumer interest. Besides also looks at trends that are shaping consumer behaviour and the broad consumer landscape. \nYou can follow Rupali on Twitter@Rupalijee.

End of Article
FOLLOW US ON SOCIAL MEDIA